These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 12166030)
1. Natural products in drug discovery--organizing for success. McChesney JD P R Health Sci J; 2002 Jun; 21(2):91-5. PubMed ID: 12166030 [No Abstract] [Full Text] [Related]
2. U.S. research earmarks. Building a scientific legacy on a controversial foundation. Mervis J Science; 2008 Jul; 321(5888):480-3. PubMed ID: 18653857 [No Abstract] [Full Text] [Related]
3. Natural product drug discovery and development: the United States National Cancer Institute role. Cragg GM P R Health Sci J; 2002 Jun; 21(2):97-111. PubMed ID: 12166031 [No Abstract] [Full Text] [Related]
4. Drug buddies. Ledford H Nature; 2011 Jun; 474(7352):433-4. PubMed ID: 21697923 [No Abstract] [Full Text] [Related]
5. Dundee: discovering life sciences. Tasker H Drug Discov Today; 2006 May; 11(9-10):379-82. PubMed ID: 16635798 [No Abstract] [Full Text] [Related]
6. Research funding. Measuring the results of science investments. Lane J; Bertuzzi S Science; 2011 Feb; 331(6018):678-80. PubMed ID: 21310987 [No Abstract] [Full Text] [Related]
7. Biomedical research. Scripps and USC consider union, for money and prestige. Service R Science; 2014 Jun; 344(6191):1435-6. PubMed ID: 24970056 [No Abstract] [Full Text] [Related]
8. Partnerships between philanthropy, government and industry are needed to advance drug discovery for neurodegenerative diseases. Refolo LM; Fillit HM Curr Alzheimer Res; 2006 Jul; 3(3):175-6. PubMed ID: 16842090 [No Abstract] [Full Text] [Related]
9. [Therapeutic monoclonal antibodies in the French community: let's get organized]. Watiez D; Watier H Med Sci (Paris); 2009 Dec; 25(12):1189-92. PubMed ID: 20035704 [No Abstract] [Full Text] [Related]
10. The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration. Vitiello B; Heiligenstein JH; Riddle MA; Greenhill LL; Fegert JM Biol Psychiatry; 2004 Jul; 56(1):3-9. PubMed ID: 15219466 [TBL] [Abstract][Full Text] [Related]
11. Universities, key to prosperity. Holliday CO Science; 2012 Jun; 336(6088):1482. PubMed ID: 22700659 [No Abstract] [Full Text] [Related]
13. CTSA program continues 'on track' despite backlog. Samson K Ann Neurol; 2009 Sep; 66(3):A9-13. PubMed ID: 19810089 [No Abstract] [Full Text] [Related]
14. Modernizing US academic research facilities. Blakey C FASEB J; 1987 Sep; 1(3):243-6. PubMed ID: 3623001 [No Abstract] [Full Text] [Related]
15. Preclinical drug development. Brodniewicz T; Grynkiewicz G Acta Pol Pharm; 2010; 67(6):578-85. PubMed ID: 21229871 [TBL] [Abstract][Full Text] [Related]
16. Glasgow and the West of Scotland region--bioscience buds beginning to bloom. O'Neill MF Drug Discov Today; 2006 May; 11(9-10):387-90. PubMed ID: 16635800 [No Abstract] [Full Text] [Related]
17. Uneasy alliance--clinical investigators and the pharmaceutical industry. Bodenheimer T N Engl J Med; 2000 May; 342(20):1539-44. PubMed ID: 10816196 [No Abstract] [Full Text] [Related]
18. The future for partnerships between universities and industry. Richmond MH Am J Med; 1995 Dec; 99(6A):81S-83S. PubMed ID: 8585547 [No Abstract] [Full Text] [Related]
19. Intellectual property issues in a clinical trial: a corporate perspective. Fersko RS; Connolly MJ Qual Assur; 1992 Jun; 1(3):237-48. PubMed ID: 1344679 [No Abstract] [Full Text] [Related]
20. Industry support of researchers in universities and academic medical centers. Gorski A JAMA; 2001 May; 285(18):2325-6. PubMed ID: 11343471 [No Abstract] [Full Text] [Related] [Next] [New Search]